12:00 AM
Dec 19, 2011
 |  BC Week In Review  |  Company News  |  Deals

Molecular Imaging Inc., Dana-Farber Cancer Institute deal

The institute granted CRO Molecular Imaging rights to luciferase-enabled cancer cell lines. The CRO said...

Read the full 54 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >